Phytofabrication of bioinduced silver nanoparticles for biomedical applications.

Synthesis of nanomaterials holds infinite possibilities as nanotechnology is revolutionizing the field of medicine by its myriad applications. Green synthesis of nanoparticles has become the need of the hour because of its eco-friendly, nontoxic, and economic nature. In this study, leaf extract of Rosa damascena was used as a bioreductant to reduce silver nitrate, leading to synthesis of silver nanoparticles (AgNPs) in a single step, without the use of any additional reducing or capping agents. The synthesized nanoparticles were characterized by the use of UV-visible spectroscopy, fourier transform infrared spectroscopy, dynamic light scattering, transmission electron microscopy, and field emission scanning electron microscopy. Time-dependent synthesis of AgNPs was studied spectrophotometrically. Synthesized AgNPs were found to possess flower-like spherical structure where individual nanoparticles were of 16 nm in diameter, whereas the agglomerated AgNPs were in the range of 60-80 nm. These biologically synthesized AgNPs exhibited significant antibacterial activity against Gram-negative bacterial species but not against Gram-positive ones (Escherichia coli and Bacillus cereus). Anti-inflammatory and analgesic activities were studied on a Wistar rat model to gauge the impact of AgNPs for a probable role in these applications. AgNPs tested positive for both these activities, although the potency was less as compared to the standard drugs.

Introduction

Nanobiotechnology is an interdisciplinary field traversing both nanotechnology and biological sciences, concerning the utilization of biological systems to fabricate functional nanoscale architectures comprising of organic and inorganic materials. This technical approach to biology has allowed scientists to imagine and create systems that can be used to study the cell as a biological molecular machine at the nanoscale level.1–3

Biological systems often feature natural, functional nanomaterials, eg, butterfly wing scale, natural colloids (milk), horny material (skin, claws, beaks, hair, and feather), and even our bone matrix. This provides credence to the fact that nature is absolutely capable of fabrication of nanoparticles and nanomaterials on its own and that this particular aspect can be harnessed by the researchers to overcome the drawbacks associated with chemical synthesis of nanoparticles. This use of biological entities to create nanoparticles has been designated as “green synthesis” and is considered to be far more beneficial since it is economical, eco-friendly, and applicable for large-scale synthesis as it operates on low pressure, less input of energy, and low temperatures. The lack of toxic byproducts and consequent decrease in degradation of the product renders this technique more preferable over physical and classical chemical methods. The variety in the plant species having reduction properties to produce nanoparticles makes them an ideal candidate for fabrication since the milieu present for synthesis determines the morphology, properties of nanoparticles, and owing to the differences in reducing capacities, capping properties, stabilizing properties among various species; plants provide an excellent platform for the control of these properties. The relatively higher stability of nanoparticles produced by plant sources as compared to microbial ones further tip the scales in favor of synthesis utilizing plant sources. Various plants can be employed for the nanoparticle synthesis such as Cinnamomum camphora, Medicago sativa, Pelargonium graveolens, Avena sativa, Azadirachta indica, Tamarindus indica, Emblica officinalis, Aloe vera, Coriandrum sativum, Carica papaya, Parthenium hysterophorus, Acanthella elongata, Sesuvium portulacastrum, Chrysanthemum indicum L, Melia azedarach L, Saraca indica, Caesalpinia coriaria, Vitex negundo L.4–25 Biomolecules like honey can also be used for the synthesis of gold nanoparticles.26,27 A variety of nanoparticles exhibiting numerous shapes such as spherical, octahedral, nanoprisms, tetrahedral, suboctahedral, irregular shaped, nanotriangles, decahedral multiple twinned, icosahedral multiple twinned, hexagonal platelets, nanorods, etc, with sizes varying from 1 to 100 nm have been produced by exploiting plant sources.28,29 Because of their submicroscopic size and unique material characteristics, manufactured nanoparticles may find practical applications in a variety of areas including medicine, engineering, catalysis, and in bioelectronics.30,31

Physical and chemical properties of materials at the nanoscale level are radically transformed because of high surface area to volume ratio. Owing to this, nanomaterials possess high catalytic activity while various bulk materials lack these properties.

Silver nanoparticles (AgNPs) have tremendous potential applications in radically different fields ranging from textiles to water purification and from electronics and cosmetics to medicine because of their unique physical, chemical, and biological properties. AgNPs are well known to possess inhibitory and bactericidal properties which might provide a solution to the increasing trend of antibiotic resistance exhibited by pathogenic bacteria that has materialized in recent years.32,33 This is an area where AgNPs might prove to be exceptionally valuable to the medical community. Nanoparticles have been proven to be a valuable ally in the fight against several diseases. Gold nanoparticles used against various cancers have often resulted in positive effects by decreasing the chemoresistance of the tumor.34–36 AgNPs have been implicated in induction of apoptosis in neutrophils and inhibition of de novo protein synthesis.37 Moreover, they are increasingly being used in antimicrobial agents for augmentation of their potencies.23–25,38,39 AgNPs are widely being used and examined in areas such as biosensing, photonics (as spectrally selective coatings for solar energy absorption), electronics (as an intercalation material for electrical batteries), antimicrobial application, and are also used as potential optical receptors for biolabeling.40–42

The main aim of this study was to synthesize AgNPs using aqueous leaves extract of Rosa damascena as bioreducing agent to reduce Ag+ to Ag0, which were later analyzed and characterized by using ultraviolet–visible (UV–Vis) spectroscopy, fourier transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM), dynamic light scattering (DLS), and field emission scanning electron microscopy (FESEM). After characterization, the in vitro antimicrobial, anti-inflammatory, and analgesic activities of the green synthesized AgNPs were evaluated.

Materials and methods

Chemicals and reagents

All the chemicals used, including silver nitrate (AgNO3), were procured from Sigma-Aldrich Co., (St Louis, MO, USA) and were of high grade analytical quality. Deionized water was used for the entire duration of the experiments. Fresh and healthy leaves of R. damascena were harvested from School of Biotechnology, IFTM University, Moradabad, Uttar Pradesh, India.

Biogenesis of AgNPs: preparation of plant leaf extract

Healthy leaves of R. damascena were washed twice with distilled water, cut into fine pieces, and dried in a hot air oven at 60°C for 4 hours. Dried leaves were grounded using mortar and pestle to obtain a fine powder. Ten grams of sterilized leaf powder was added in 100 mL distilled water and boiled for 30 minutes in a water bath at 100°C. This mixture was cooled to room temperature and then filtered using Whatman filter paper. This filtered leaf extract was stored at −30°C till further use and has been used as obtained in all the experiments unless stated otherwise.

Biosynthesis of AgNPs

AgNPs were synthesized according to the procedure described in our previous study.43 The aqueous solution of 1 mM AgNO3 was prepared and used for the synthesis of AgNPs. Approximately 10 mL of R. damascena extract was added to 90 mL aqueous solution of 1 mM AgNO3 for reduction into Ag0 ions and was incubated for a period of 15 minutes with vigorous stirring using magnetic stirrer at room temperature. A rapid change in color was observed indicating the initiation of the generation of AgNPs. The resultant mixture of AgNPs and extract obtained after the synthesis was kept under mild stirring conditions for 24 hours. The obtained mixture was then purified by centrifugation at 10,000 rpm for 15 minutes, and this was followed by dispersion of the pellet in deionized water.

Characterization of AgNPs

The synthesized AgNPs, and the effect of the extract on the synthesis were characterized by UV–Vis spectroscopy, FTIR, DLS, TEM, and FESEM.

UV–Vis spectrophotometric analysis

UV–Vis spectra of the samples were analyzed by PerkinElmer UV–Vis double beam spectrophotometer. The scanning range for the samples was 300–600 nm, operated at a resolution of 1 nm. Deionized water was used as blank.

FTIR spectroscopy

FTIR spectrum of AgNPs and leaf extract was recorded using PerkinElmer Spectrum BX, FT-IR (PerkinElmer, Akron, OH, USA) at room temperature through potassium bromide pellet method. NPs was dispersed into KBr matrix, mixed well, and pelletized. The pellet was kept in IR path and spectrum was measured in the 400–4,000 cm−1 range. FTIR spectroscopy measurements were carried out to recognize the biogroups that are attached on the surface of AgNPs from the leaf extract used for the synthesis.

Transmission electron microscopy analysis

The morphology and particle size of synthesized AgNPs were determined by TEM using a Hitachi Model H-7500 (Hitachi Ltd., Tokyo, Japan) with an acceleration voltage of 200 kV.

Dynamic light scattering spectroscopy

The size distribution of AgNPs was carried out by DLS spectrophotometer (DynaPro-TC-04; Protein Solutions, Santa Barbara, CA, USA) equipped with a temperature-controlled microsampler. The mean hydrodynamic radius (Rh) was measured by using the Stokes–Einstein equation: where Rh is the hydrodynamic radius, k is Boltzmann’s constant, T is absolute temperature, η is the viscosity of solvent, and D is translational diffusion coefficient.

Field emission scanning electron microscopy

The surface morphology of AgNPs was determined by FESEM, JEOL JSM 6700F (JEOL, Tokyo, Japan).

Effect of temperature on AgNPs synthesis

The effect of temperature on the rate of synthesis of AgNPs was studied by adding 90 mL of 1 mM AgNO3 solution to 10 mL R. damascena leaf extract and carrying out the biosynthesis at different temperatures, viz, 10°C, 20°C, 30°C, 40°C, and 50°C for up to 6 hours. The formation of AgNPs was observed by their color change and further validated spectrophotometrically.

Test for phenolic compounds

Ferric ion reduction test was performed to identify the presence of phenolic compounds in R. damascena leaf extract. In this test, FeCl3 solution (30 mM) was added to plain R. damascena leaf extract solution and to the supernatant left behind after the synthesis of AgNPs. The color change of the leaf extract was observed to detect the presence of phenolic compounds. Hydrolysable tannins give blue black color initially and later condense exhibiting brownish green color with precipitation as a consequence of formation of ferrous compounds.44

Screening for antibacterial properties

The synthesized nanoparticles were studied for their antibacterial action against the Gram-positive and Gram-negative bacteria. Escherichia coli (Gram-negative) and Bacillus cereus (Gram-positive) were used as the targets in the bactericidal assay. The cultures were cultivated in broth for 24 hours before inoculation on the assay plate. Three wells of 7 mm diameter were prepared on Mueller Hinton agar plate with the use of gel puncture. The cultures were inoculated onto the assay media with a sterile cotton swab. Leaf extract was added to the first well to act as a control, penicillin was added to the second and 25 µL of synthesized particles was inoculated to the third well. The plates were incubated for 37°C for 24 hours; the zones of inhibition were observed.

Test for anti-inflammatory properties of AgNPs on rat model

In vivo study: experimental animals and conditions Wistar albino rats (150–200 g) were selected, housed in polypropylene cages in an air conditioned area at 23°C±2°C, 50%–60% relative humidity with 10 hours/14 hours light and dark cycle, and allowed to acclimatize for 14 days before tests. Animals were allowed free access to slandered dry pellet diet and given water ad libitum. Animals were kept in plastic rat cages throughout the entire experiment; food was not given to the animals 12 hours before drug administration study. The litter in the cages was renewed thrice a week to ensure hygiene and maximum comfort for animals. The Institutional Animal Ethical Committee (IAEC) at IFTM University, Moradabad, Uttar Pradesh, India (Protocol approval number 2012/837/AC/PhD/05) approved the protocol for this study.

The experimental animals were divided into three groups with six animals each.

Carrageenan-induced paw edema method

For the carrageenan-induced paw edema study, the groups were treated as following:

Group 1 served as control.

Group 2 served as standard – treated with 10 mg/kg of indomethacin orally.

Group 3 served as test group – treated with AgNPs colloidal suspension 0.3 mg/kg body weight orally.

Procedure

Anti-inflammatory activity was studied in three groups of six rats each. The AgNP colloidal suspension was orally administered daily for 4 days prior to injection of carrageenan. Edema was induced according to the method described by Patil et al.45 Briefly, 0.1 mL of 1% carrageenan in sterile saline was injected into one hind paw under the plantar aponeurosis. A similar volume of saline solution was injected into the other hind paw. The paw volume was measured before injection of carrageenan or saline by the digital plethysmograph, and the time course of edema formation was followed over 3 hours. In separate groups of animals, indomethacin 10 mg/kg of body weight was administered orally as standard drug and 1% carboxymethyl cellulose solution as solvent control. A fixed amount of AgNPs 0.3 mg/kg body weight (0.19 mg/mL) was administered orally 30 minutes before carrageenan injection. The dosage was decided on the basis of previously studied literature.46 The volume increase of the inflamed paw was estimated by subtracting the volume of the contralateral paw. The anti-inflammatory effect of the drugs was evaluated as the degree of edema inhibition.47

Evaluation parameters

Percentage inhibition in edema was calculated using the formula: where % I and I are the mean inflammation values reached in control and experimental groups. Inhibition in edema represents the inhibition of the inflammation. Edema was determined by measuring the paw volume using a digital plethysmometer.

Test for analgesic activity on rats: radiant heat tail-flick model

Radiant heat tail-flick model in rats was employed to establish the central analgesic activity.48 This was achieved by studying and measuring changes in the sensitivity of the prescreened rats (the intensity of the light being experimentally defined such that animals withdrew their tails within 2–4 seconds) to heat stress applied to their tails, after introducing the drugs into their system. Tail-flick latency was assessed by the analgesiometer. All the drugs were provided orally to the respective group of rats. The current delivered through the nichrome wire, acting as the heat source, was maintained steadily at 5 A. The standard pentazocine dosage was kept at 30 mg/kg, whereas AgNPs were administered at a dose of 0.025 mg/mL. The gap amid the heat source (nichrome wire) and the tail was kept constant at 1.5 cm, with the application site of the heat on the tail being maintained within 2 cm from the base of the tail. The cutoff reaction time was set to +10 seconds to avoid any tissue injury during the process. Tail-flick latency was considered from +30 minutes after the drug administration.

Evaluation

The time taken by rats to withdraw (flick) the tail was taken as the reaction time. The animals were subjected to the same test procedure at +30, +60, +120, and +180 minutes after the administration of test/standard/control drug.

Statistical analysis

All data were expressed as mean ± standard error of mean (n=6) and analyzed using one way analysis of variance (ANOVA) followed by Dunnett’s test.

Results

AgNPs appear dark reddish brown in color in aqueous solution due to excitation of surface plasmon resonance, which is a signature feature of AgNPs. When the extract was added to the aqueous solution of AgNO3 under vigorous stirring by magnetic stirrer at room temperature, the color changed from colorless to brownish yellow within 5 minutes (changed to dark reddish brown 15 minutes later). After 24 hours, no further color change was observed, signifying the stability of the synthesized nanoparticles. The results are shown in Table 1.

Table 1

Color change during synthesis of nanoparticles

Serial number	Aqueous AgNO3 color	Color change in 5 minutes	Color change in 15 minutes	Color change after 24 minutes
1	White transparent	Brownish yellow	Dark reddish brown	No change still dark reddish brown

Abbreviation: AgNO3, silver nitrate.

The appearance of the reddish brown color was only due to the reduction of Ag+, which confirms the formation of Ag nanoparticles as shown in Figure 1 (A and B).

Figure 1

Synthesis of silver nanoparticles.

Notes: (A) AgNO3 solution; (B) synthesized silver nanoparticles exhibiting brown color.

Abbreviation: AgNO3, silver nitrate.

Characterization of AgNPs: UV-Vis spectrophotometeric analysis

This color change is considered to be a standard indicator for synthesis of AgNPs. The UV–Vis spectrum of AgNPs synthesized by R. damascena is shown in Figure 2. The distinct peak observed at 415 nm corresponds to surface plasmon resonance of AgNPs.

Figure 2

UV–Vis analysis of AgNPs.

Abbreviations: AgNPs, silver nanoparticles; UV–Vis, ultraviolet–visible.

The presence of the dark brown color and the peak at 415 nm implies the synthesis of AgNPs.

FTIR analysis

FTIR spectrum of the synthesized AgNPs and the leaf extract has been displayed in Figure 3. The FTIR spectrum of leaf extract (Figure 3) shows several absorption peaks at 3,399, 2,135, 1,640, 1,074, 726, and 407 cm−1. The intense broad line at 3,399 cm−1 is characteristic of the hydroxyl functional group in alcohols and phenolic compounds due to the stretching vibrations. Among all these, the peaks at 3,399, 2,135, and 1,640 cm−1 appeared similarly in the spectrum of AgNPs (Figure 4). The bands at 2,135 cm−1 could be due to weak alkyne C≡C stretching which is associated with lipid molecules in the leaf broth. The band at 1,640 cm−1 is due to amide II bond conjugated at C=O from proteins. The bands at 1,375 cm−1 in AgNPs corresponded to –C–O– stretching vibration. The weak bands appearing at 1,074 and 1,042 cm−1 in spectra of leaf extract and AgNPs, respectively, was due to –C–C– stretches of lipids and sugars. The bands around 720, 750, and 693 cm−1 can be assigned to phenyl (C–H) stretch, respectively. The bands at 2,284, 1,381, 1,054, and 613 cm−1 disappeared completely from the spectrum of AgNPs.

Figure 3

FTIR spectrum for Rosa damascena extract.

Abbreviation: FTIR, Fourier transform infrared spectroscopy.

Figure 4

FTIR spectrum for the synthesized AgNPs.

Abbreviations: FTIR, Fourier transform infrared spectroscopy; AgNPs, silver nanoparticles.

The dual role of the plant extract as a reducing as well as a capping agent and the presence of some functional groups was confirmed by FTIR analysis of AgNPs. These results suggested that the AgNPs have been synthesized due to the action of extract of the plant, R. damascena, which can act as a potentially good bioreductant for biosynthesis.

TEM analysis

TEM technique was used to visualize the size and shape of synthesized AgNPs through leaf extract of R. damascena. It is evident from Figure 5, that most of the synthesized particles were polydispersed, irregular in shape, and flower-like. The average size of the individual nanoparticles was estimated ~16 nm, whereas polydispersed particles were in the range of 60–80 nm. The maximum size and minimum size of synthesized individual AgNP were found to be 24.6 and 11.6 nm, respectively.

Figure 5

TEM micrograph shows the size of synthesized silver nanoparticles.

Abbreviation: TEM, transmission electron microscopy.

DLS measurement analysis

DLS measurement was performed to investigate the size and polydispersity of synthesized AgNPs. The hydrodynamic radii (Rh) of AgNPs were found to be in range of 30–100 nm (Figure 6). As evident by the intensity, the maximum nanoparticles were on average 60 nm, with 50 and 80 nm being the next most prominent sizes. Since the TEM study showed that the average size of synthesized individual nanoparticles is 16 nm, the increase in size can be attributed to polydispersion of nanoparticles. This study confirms that the particles synthesized are indeed under 100 nm and can be classified as nanoparticles.

Figure 6

DLS analysis of synthesized nanoparticles.

Abbreviation: DLS, dynamic light scattering.

FESEM analysis

The surface morphology of AgNPs was investigated using FESEM. The micrographs (Figure 7A and B) showed that synthesized AgNPs have rough surfaces and spherical and uneven irregular beads of different sizes. The result indicates the reduction process is being held at the surface. The rough surface may be advantageous for the immobilization of enzymes. As we can see from the micrograph, the nanoparticles were not in direct contact even within the aggregates, indicating stabilization of the nanoparticles by a capping agent.

Figure 7

SEM imaging of AgNPs (A) at 300 nm scale; (B) at 500 nm scale.

Abbreviations: SEM, scanning electron microscopy; AgNPs, silver nanoparticles.

Effect of temperature on synthesis of AgNPs

The effect of temperature on the rate of biosynthesis was examined by using different temperatures for the reaction, from 10°C to 50°C for up to 6 hours, and was analyzed by measuring the absorbance at 420 nm using a UV–Vis double beam spectrophotometer. At lower temperatures, it was found that the rate of reaction was quite slow. From 10°C to 30°C, the reaction rate did not increase significantly with increase in temperature, but as the temperature was elevated to 40°C, a significant increase in the rate of reaction was observed. The reaction rate of synthesis of AgNPs was found to be quite similar at 40°C and 50°C. The reduction of Ag ions reached its maximum after 5 hours, which could correspond to complete reduction of silver ions. The maximum reaction rate and reduction was obtained at 40°C, and hence it was deemed as optimum temperature for reaction. Figure 8 shows the synthesis of AgNPs at different temperatures with respect to time.

Figure 8

Effect of temperature on AgNPs synthesis.

Abbreviation: AgNPs, silver nanoparticles.

Test for phenolic residues and bound phenol

The role of phenolic compounds was confirmed by performing ferric ion reduction test. Addition of the ferric chloride solution to the R. damascena extract causes the color to change to bluish black and leads to precipitation later. This precipitation and color change indicates the presence of condensed tannins in the leaves extract. No color change was observed with the supernatant of leaf extract obtained after the synthesis of AgNPs after addition of ferric chloride solution (Figure 9). This test affirms that the phenolic compounds in the R. damascena extract were responsible for the reduction of AgNO3 to AgNPs and that no phenolic residues are present in the leaf extract after the synthesis, exemplifying that the phenol or phenolic compounds have been utilized during the synthesis.

Figure 9

Ferric ion reduction test.

Notes: (A) Ferric chloride solution; (B) color change in Rosa damascena extract.

Antibacterial efficacy of synthesized nanoparticles

The antibacterial activity of AgNPs against E. coli was found to be higher than that against B. cereus, which may be a consequence of the disparity in the cell wall constitution between Gram-positive and Gram-negative bacteria (Figure 10). The exact mechanism of such a reaction has not been elucidated yet. The plate with Gram-negative bacteria had clear zones of inhibition for penicillin and AgNPs, whereas no such zone was present in the Gram-positive bacterium plate. The leaf extract acting as control showed no zone of inhibition in either plate, indicating that the antibacterial activity of AgNPs is independent of the leaf extract used. The antibacterial activity was found to be lesser than penicillin, judging by the zone of inhibition, but the presence of antibacterial activity can be used in concomitance with other antimicrobial agents to increase their efficacy.

Figure 10

Antibacterial action of synthesized AgNPs.

Notes: (A) Against Escherichia coli; (B) against Bacillus cereus.

Abbreviation: AgNPs, silver nanoparticles.

AgNPs were able to produce a significant anti-inflammatory action in the rat model. The effectiveness of the synthesized AgNPs was at its maximum for the 1st hour, judging by the decrease in paw volume between 30 minutes and 1 hour. By the 2-hour mark, the effectiveness started to reduce, but the effect was still significant. After the completion of 3rd hour, the effectiveness starts to tail off, but is still in the significant range. This action was compared to the action of the standard indomethacin, which was found to be quite significant even after 3 hours. The results have been presented graphically in Figure 11. These results show that even though AgNPs on their own are not as effective as the standard drugs for reducing the inflammation, it nevertheless presents us with an interesting option to be used in union with the standard drugs, to augment their effectiveness. These results are in concurrence with earlier studies which state that AgNPs do possess anti-inflammatory properties.46,49 The data is presented in the form of Table 2. Results are expressed as mean ± standard error of mean (n=6) analyzed by one way ANOVA followed by Dunnett’s test.

Figure 11

Anti-inflammatory properties of AgNPs vs standard indomethacin.

Notes: *P<0.05, **P<0.01, ***P<0.001, when control group compared with other treated groups.

Abbreviations: AgNPs, silver nanoparticles; min, minute; h, hour.

Table 2

Decrease in mean paw volume after administration of control, standard, and AgNPs with respect to time

Serial number	Drugs (dose)	Mean paw volume in mL ± SEM, n=6, and percentage edema inhibition
		0 minute	30 minutes	1 hour	2 hours	3 hours
1	Control (1% CMC) (10 mL/kg)	1.88±0.01	2.06±0.04	2.16±0.05	2.31±0.04	2.43±0.06
2	Standard indomethacin (10 mg/kg)	1.6±0.08	1.69±0.03*	1.56±0.04*	1.5±0.02*	1.53±0.06**
3	AgNPs	1.65±0.02	1.9±0.04*	1.75±0.06**	1.8±0.08***	1.84±0.08***

Notes:

P<0.001,

P<0.01,

P<0.05, when control group compared with other treated groups.

Abbreviations: AgNPs, silver nanoparticles; SEM, standard error of the mean; CMC, carboxymethyl cellulose.

Test for analgesic activity on rats

Tail-flick test was performed on the part of the tail within 2 cm from root. Thermal stimulus typically pertains to the superficial surface of the skin, and the energy due to stimulus absorbed in the skin is intensified in the dermal/epidermal junction because of the location of nerve terminals; therefore, this particular assay method is particularly valuable in investigating the effect of analgesics. Analgesic activity was examined by digital analgesiometer. The decrease in the tail withdrawal time after application of AgNPs suggested that it might have some antianalgesic properties. The inhibition percentage was 16.74% as compared to 44.70% exhibited by pentazocine, which shows that even though AgNPs are not as effective as the standard drugs, they still exhibit an antianalgesic effect and can be used in conjunction with other standard antianalgesic agents to increase their efficacy. These results are in accordance with the previous studies which state that AgNPs do exhibit significant analgesic activities.50 The data has been presented in Table 3 and is represented graphically in Figure 12. Results are expressed as mean ± standard error of mean (n=6) analyzed by one way ANOVA followed by Dunnett’s test.

Table 3

Protective effect of AgNPs on tail withdrawal reflexes in rats determined by tail-flick method

Serial number	Drugs (dose)	Before treatment (mean ± SEM)	After treatment (mean ± SEM)	Percentage inhibition (%)
1	Control	6.03±0.176	5.9±0.106	0.00
2	Pentazocine (30 mg/kg)	5.86±0.149	8.48±0.382*	44.70
3	AgNPs (0.025 mg/mL)	6.15±0.178	7.18±0.242**	16.74

Notes:

P<0.001,

P<0.05, when control group compared with other treated groups.

Abbreviations: AgNPs, silver nanoparticles; SEM, standard error of the mean.

Figure 12

Protective effect of AgNPs on tail withdrawal reflexes induced by tail-flick method in rat.

Notes: *P<0.05, ***P<0.001, when control group compared with other treated groups.

Abbreviation: AgNPs, silver nanoparticles.

Conclusion

In summary, biological reduction of AgNPs was achieved using R. damascena leaf extract without any use of chemicals, making this technique for synthesis invaluable for the environmental concerns. The synthesis was accomplished under high temperature with vigorous stirring and the created nanoparticles were characterized using several techniques, viz, UV–Vis spectroscopy, FTIR, DLS, TEM, and FESEM. The individual nanoparticles were found to be of 16 nm in size, whereas polydispersed nanoparticles were in the range of 60–80 nm on average, having rugged surface morphology and possessing a flower-like structure. The reducing properties of leaf extract were attributed to phenolic compounds present in the extract, as evident by the test conducted for presence of phenolic compounds in the extract before and after synthesis. The leaves were sterilized before the extraction, for the removal of contaminants inhabiting the surface, and this may well be the first study to do so. Although the green synthesis is far more economical as compared to the other technologies for synthesis of nanoparticles, the commercial viability of the process for the synthesis of nanoparticles using these swiftly obtainable plant extracts must be assessed before employing them on a large scale.

The synthesized AgNPs exhibited a strong antibacterial activity against Gram-negative bacterium E. coli, but not against B. cereus, which is a Gram-positive bacterium. This difference in action could be ascribed to the difference in cell wall composition, but the exact mechanism of antibacterial action of AgNPs has not been explicated yet. The anti-inflammatory and analgesic properties of the nanoparticles were tested on Wistar rats. AgNPs were found to possess anti-inflammatory as well as analgesic properties, although the activity was quite less as compared to the standards in both the cases. The anti-inflammatory activity was found to be at its maximum after 1 hour of AgNP administration and was significant even after 3 hours, but was a fraction of the activity demonstrated by the standard indomethacin. The analgesic activity, calculated using percentage inhibition, showed that AgNPs reduced the time between the tail flicks by 16.74% as compared to 44.70% achieved by the standard, pentazocine, which illustrated that analgesic action of AgNPs is not as potent as the standard drugs, but the presence of small quantities of antibacterial, anti-inflammatory, and analgesic activity can be used in conjunction with the standard drugs to enhance their efficacy.